FDA Says Shortage Ends for Cancer Drug Cytarabine

The FDA said that shortages of cytarabine, a cancer drug, has been resolved, but other critical drug shortages still remain, according to a Fox Business report.

Advertisement

The shortage began last year when manufacturing experienced complications getting active ingredients, producing a quality product and keeping up with demand. The FDA reported 178 drug shortages last year and has said the number is even greater so far this year.

Related Articles on Drug Shortages:
Drug Shortages Increasingly Take Toll on Care
American Society of Anesthesiologists Present at FDA Workshop on Drug Shortages
Federal Government Scrutinizes Drug Shortages With ASA Backing

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.